These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 33037466

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
    Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J, Sasaki H, Park S, Kryukov G, Garraway LA, Hammerman PS, Haas J, Andrews SW, Lipson D, Stephens PJ, Miller VA, Varella-Garcia M, Jänne PA, Doebele RC.
    Nat Med; 2013 Nov; 19(11):1469-1472. PubMed ID: 24162815
    [Abstract] [Full Text] [Related]

  • 3. A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H.
    Li P, Hou F, Wang S, Luo N, Qi Y, Wang Y.
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2483-2486. PubMed ID: 33811536
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY, Choi C, Shin E, Lee JH, Kwon CH, Jo HJ, Kim HR, Kim HS, Oh N, Lee JS, Park OK, Park E, Park J, Shin JY, Kim JI, Seo JS, Park HD, Park J.
    Oncotarget; 2016 Feb 16; 7(7):8399-412. PubMed ID: 26716414
    [Abstract] [Full Text] [Related]

  • 6. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H, Xue X, Ding H, Ou Q, Wu X, Nagasaka M, Shao YW, Hu X, Ou SI.
    Clin Lung Cancer; 2020 May 16; 21(3):247-254. PubMed ID: 31761448
    [Abstract] [Full Text] [Related]

  • 7. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM, Haugh AM, Lee CY, Zhang B, Bubley JA, Merkel EA, Verzì AE, Gerami P.
    Am J Surg Pathol; 2017 Apr 16; 41(4):491-498. PubMed ID: 27776007
    [Abstract] [Full Text] [Related]

  • 8. Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
    Hochmair MJ, Setinek U, Krenbek D, Fazekas A, Illini O, Weinlinger C, Draxler H, Marcher M, Valipour A, Müllauer L, Beer L.
    Clin Lung Cancer; 2020 Mar 16; 21(2):e49-e53. PubMed ID: 31879191
    [No Abstract] [Full Text] [Related]

  • 9. A novel TNIP2-RET fusion identified in a patient with mucinous adenocarcinoma of the lung.
    Ren P, Luo N, Qi Y, Wu Y, Jin M.
    Lung Cancer; 2021 Mar 16; 153():179-181. PubMed ID: 33478856
    [No Abstract] [Full Text] [Related]

  • 10. PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma.
    Yang L, Zhao W, Zhu H, Li X, Zhao G.
    Lung Cancer; 2021 Apr 16; 154():219-220. PubMed ID: 33676770
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.
    Zhang L, Liu H, Tian Y, Wang H, Yang X.
    BMC Pulm Med; 2021 Apr 17; 21(1):125. PubMed ID: 33865348
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.
    J Natl Cancer Inst; 2016 Jan 17; 108(1):. PubMed ID: 26563355
    [Abstract] [Full Text] [Related]

  • 14. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 17; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.
    Ge J, Yao B, Huang J, Wu X, Bao H, Ou Q, Shao YW, Chen J.
    BMC Cancer; 2019 Jun 17; 19(1):592. PubMed ID: 31208361
    [Abstract] [Full Text] [Related]

  • 17. NTRK1 is a positive regulator of YAP oncogenic function.
    Yang X, Shen H, Buckley B, Chen Y, Yang N, Mussell AL, Chernov M, Kobzik L, Frangou C, Han SX, Zhang J.
    Oncogene; 2019 Apr 17; 38(15):2778-2787. PubMed ID: 30542115
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
    Créancier L, Vandenberghe I, Gomes B, Dejean C, Blanchet JC, Meilleroux J, Guimbaud R, Selves J, Kruczynski A.
    Cancer Lett; 2015 Aug 28; 365(1):107-11. PubMed ID: 26001971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.